Oncolytics Biotech stock lacks a fresh catalyst and stays near $0.77

Published on 09/19/2026 at 16:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Oncolytics Biotech stock traded at $0.77 on September 18, 2026, with a market cap near $98 million. The latest quarterly figures in the available market data point to continued losses.

ONCY, CA6823101073, Illustration mit AI erstellt.

Oncolytics Biotech Inc. (ISIN CA6823101073) stock traded at $0.77 on September 18, 2026, while market data put its capitalization near $98 million. The quote also showed a 12-month change of minus 9.0 percent, which keeps the shares close to the lower end of the small-cap range.

Latest figures stay in view

As ad hoc news reported on September 19, 2026, Oncolytics Biotech was priced at $0.77 in the market comparison data, and the same snapshot showed a market cap of $98 million and a 12-month performance of minus 9.0 percent.

For the latest reported operating context, the available market summary points to revenue of 0 and a net margin that remains negative, while the comparison set leaves the stock at a price-to-sales readout of 0.0.

What investors track

The most important read-through for investors is the gap between a $98 million market value and the absence of a visible earnings turnaround in the available summary data. That combination leaves the next company update more important than the day-to-day quote.

Stock near the low end

Oncolytics Biotech stock last traded at $0.77 on September 18, 2026, with the market cap near $98 million as of the same snapshot. The 12-month move of minus 9.0 percent shows how far the shares remain from a sustained recovery.